Resources Contact Us Home
Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof

Image Number 14 for United States Patent #8106164.

The invention pertains to the development of antibodies that specifically bind amyloid beta protein (Abeta) in its protofibril conformation. The invention also comprises methods of using anti-Abeta protofibril antibodies to diagnose or treat Alzheimer's disease, Down's syndrome Lewybody dementia, vascular dementia, and other neurodegenerative disorders. Furthermore, the invention pertains to the use of anti-Abeta protofibril antibodies to screen and identify substances that will modulate protofibril activity or formation in vitro or in vivo. The invention also pertains to methods for synthesising pure Abeta protofibril antigens as well as to a method for stabilising Abeta protofibrils antigens as well as to a method for stabilising Abeta protofibrils.

  Recently Added Patents
Security assembly for attachment to an object
Thermoelectric heat pump
Image forming apparatus, and control method and storage medium therefor
Shared time of flight pixel
Cyclic preparation method for producing titanium boride from intermediate feedstock potassium-based titanium-boron-fluorine salt mixture and producing potassium cryolite as byproduct
Scheduling packet transmissions
  Randomly Featured Patents
Radiator unit for engine and method of combining the same with engine
Method for performing data structure conversions
Imaging system using polarization effects to enhance image quality
High protein supplement
Arithmetic and control unit
Embroidery hoop with a tensioning device
Device for coupling two rotary machines
Therapy control based on cardiopulmonary status
Circuit board including multiple wire photosensitive adhesive
Dispensing type cap closure